Comprehensive analysis of human microRNA target networks

BioData Mining

Volumn 4, Issue 1, 2011, Pages

  Satoh, Jun Ichi ^a   Tabunoki, Hiroko ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA; TRANSCRIPTION FACTOR E2F;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CHRONIC MYELOID LEUKEMIA; GENE ACTIVATION; GENE TARGETING; GLIOMA; HUMAN; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR INTERACTION; MULTIPLE MYELOMA; NEOPLASM; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STOMACH CANCER; T CELL LEUKEMIA; T CELL LYMPHOMA; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS MYOCARDITIS;

EID: 79958851546     PISSN: None     EISSN: 17560381     Source Type: Journal    
DOI: 10.1186/1756-0381-4-17     Document Type: Article

References (30)

1. Mammalian microRNAs predominantly act to decrease target mRNA levels. H Guo NT Ingolia JS Weissman DP Bartel, Nature 2010 466 835 40 10.1038/nature09267 20703300
2. MicroRNAs: target recognition and regulatory functions. DP Bartel, Cell 2009 136 215 33 10.1016/j.cell.2009.01.002 19167326
3. Widespread changes in protein synthesis induced by microRNAs. M Selbach B Schwanhäusser N Thierfelder Z Fang R Khanin N Rajewsky, Nature 2008 455 58 63 10.1038/nature07228 18668040
4. Most mammalian mRNAs are conserved targets of microRNAs. RC Friedman KK Farh CB Burge DP Bartel, Genome Res 2009 19 92 105 18955434
5. Targeting microRNAs in cancer: rationale, strategies and challenges. R Garzon G Marcucci CM Croce, Nat Rev Drug Discov 2010 9 775 89 10.1038/nrd3179 20885409
6. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. M Shioya S Obayashi H Tabunoki K Arima Y Saito T Ishida J Satoh, Neuropathol Appl Neurobiol 2010 36 320 30 10.1111/j.1365-2990.2010.01076.x 20202123
7. Getting started in biological pathway construction and analysis. GA Viswanathan J Seto S Patil G Nudelman SC Sealfon, PLoS Comput Biol 2008 4 16 10.1371/journal.pcbi.0040016 18463709
8. A robustness-based approach to systems-oriented drug design. H Kitano, Nat Rev Drug Discov 2007 6 202 10 10.1038/nrd2195 17318209 (Pubitemid 46344624)
9. Error and attack tolerance of complex networks. R Albert H Jeong AL Barabasi, Nature 2000 406 378 82 10.1038/35019019 10935628 (Pubitemid 30625551)
10. Characterization of microRNA-regulated protein-protein interaction network. CW Hsu HF Juan HC Huang, Proteomics 2008 8 1975 79 10.1002/pmic. 200701004 18491312
11. Accurate microRNA target prediction correlates with protein repression levels. M Maragkakis P Alexiou GL Papadopoulos M Reczko T Dalamagas G Giannopoulos G Goumas E Koukis K Kourtis VA Simossis P Sethupathy T Vergoulis N Koziris T Sellis P Tsanakas AG Hatzigeorgiou, BMC Bioinformatics 2009 10 295 10.1186/1471-2105-10-295 19765283
12. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. W Huang da BT Sherman RA Lempicki, Nat Protoc 2009 4 44 57 19131956
13. New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. H Sato S Ishida K Toda R Matsuda Y Hayashi M Shigetaka M Fukuda Y Wakamatsu A Itai, Curr Drug Discov Technol 2005 2 89 98 10.2174/1570163054064701 16472233 (Pubitemid 40943979)
14. Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. JI Satoh H Tabunoki T Yamamura, Mult Scler 2009 15 531 41 10.1177/1352458508101943 19389748
15. Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus. J Satoh H Tabunoki K Arima, Dis Markers 2009 27 239 52 20037212
16. GO::TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. EI Boyle S Weng J Gollub H Jin D Botstein JM Cherry G Sherlock, Bioinformatics 2004 20 3710 15 10.1093/bioinformatics/bth456 15297299 (Pubitemid 40136825)
17. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. H Zhao A Kalota S Jin AM Gewirtz, Blood 2009 113 505 16 10.1182/blood-2008-01-136218 18818396
18. E2F1-regulated microRNAs impair TGF-dependent cell-cycle arrest and apoptosis in gastric cancer. F Petrocca R Visone MR Onelli MH Shah MS Nicoloso I de Martino D Iliopoulos E Pilozzi CG Liu M Negrini L Cavazzini S Volinia H Alder LP Ruco G Baldassarre CM Croce A Vecchione, Cancer Cell 2008 13 272 86 10.1016/j.ccr.2008.02.013 18328430 (Pubitemid 351318375)
19. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. L Boominathan, PLoS One 2010 5 10615 10.1371/journal.pone. 0010615 20485546
20. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. J Takamizawa H Konishi K Yanagisawa S Tomida H Osada H Endoh T Harano Y Yatabe M Nagino Y Nimura T Mitsudomi T Takahashi, Cancer Res 2004 64 3753 56 10.1158/0008-5472.CAN-04-0637 15172979 (Pubitemid 38697282)
21. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. LT Bemis R Chen CM Amato EH Classen SE Robinson DG Coffey PF Erickson YG Shellman WA Robinson, Cancer Res 2008 68 1362 68 10.1158/0008-5472.CAN-07-2912 18316599 (Pubitemid 351346843)
22. miR-148 regulates Mitf in melanoma cells. BS Haflidadáttir K Bergsteinsdáttir C Praetorius E Steingrímsson, PLoS One 2010 5 11574 10.1371/journal.pone.0011574 20644734
23. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. E Vreugdenhil CS Verissimo R Mariman JT Kamphorst JS Barbosa T Zweers DL Champagne T Schouten OC Meijer ER de Kloet CP Fitzsimons, Endocrinology 2009 150 2220 28 19131573
24. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. PA Gregory AG Bert EL Paterson SC Barry A Tsykin G Farshid MA Vadas Y Khew-Goodall GJ Goodall, Nat Cell Biol 2008 10 593 601 10.1038/ncb1722 18376396 (Pubitemid 351627379)
25. Human microRNAs co-silence in well-separated groups and have different predicted essentialities. G Boross K Orosz I Farkas, Bioinformatics 2009 25 1063 69 10.1093/bioinformatics/btp018 19131366
26. MicroRNA regulation of human protein protein interaction network. H Liang WH Li, RNA 2007 13 1402 8 10.1261/rna.634607 17652130 (Pubitemid 47347411)
27. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Q Cui Z Yu Y Pan EO Purisima E Wang, Biochem Biophys Res Commun 2007 352 733 38 10.1016/j.bbrc.2006.11.080 17141185 (Pubitemid 44880316)
28. Reprogramming of miRNA networks in cancer and leukemia. S Volinia M Galasso S Costinean L Tagliavini G Gamberoni A Drusco J Marchesini N Mascellani ME Sana R Abu Jarour C Desponts M Teitell R Baffa R Aqeilan MV Iorio C Taccioli R Garzon G Di Leva M Fabbri M Catozzi M Previati S Ambs T Palumbo M Garofalo A Veronese A Bottoni P Gasparini CC Harris R Visone Y Pekarsky A de la Chapelle M Bloomston M Dillhoff LZ Rassenti TJ Kipps K Huebner F Pichiorri D Lenze S Cairo MA Buendia P Pineau A Dejean N Zanesi S Rossi GA Calin CG Liu J Palatini M Negrini A Vecchione A Rosenberg CM Croce, Genome Res 2010 20 589 99 10.1101/gr.098046.109 20439436
29. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. GA Calin C Sevignani CD Dumitru T Hyslop E Noch S Yendamuri M Shimizu S Rattan F Bullrich M Negrini CM Croce, Proc Natl Acad Sci USA 2004 101 2999 3004 10.1073/pnas.0307323101 14973191 (Pubitemid 38327724)
30. MicroRNA expression profiles classify human cancers. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck A Sweet-Cordero BL Ebert RH Mak AA Ferrando JR Downing T Jacks HR Horvitz TR Golub, Nature 2005 435 834 38 10.1038/nature03702 15944708 (Pubitemid 40839735)